Feifei Ding, M.A., joined Statistics Collaborative, Inc. (SCI) in 2018.

Prior to joining SCI, Ms. Ding served as a biostatistician for three years at a contract research organization dedicated to medical device clinical trials in renal disease, respiratory disease, cardiovascular disease, and oncology. In that position, she provided comprehensive statistical support writing protocol sections, statistical analysis plans, and clinical study reports). She also generated tables, listings, and figures, configured electronic data capture systems, and provided trial data monitoring and management.

At SCI, Ms. Ding has expanded her knowledge from device trials to drug trials in several areas, including acute myeloid leukemia, non-Hodgkin’s lymphoma, age-related macular degeneration, diabetes, and bipolar disorder.

Before Ms. Ding transitioned to biostatistics, she was involved in basic science research in academia and published in several peer-reviewed journals. Her area of research was age-related transcriptional change caused by genetic and environmental interventions.

Ms. Ding received her B.S. in Industrial Engineering from Shanghai University (2000) and her M.A. in Biostatistics from Brown University (2015).